BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9233625)

  • 1. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
    Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
    Brown M; Rittenburg MB; Chen C; Roberts VA
    J Immunol; 1996 May; 156(9):3285-91. PubMed ID: 8617951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected.
    Claflin JL; Berry J
    J Immunol; 1988 Dec; 141(11):4012-9. PubMed ID: 3141511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.
    Feeney AJ; Clarke SH; Mosier DE
    J Immunol; 1988 Aug; 141(4):1267-72. PubMed ID: 3135325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of a single conserved residue in VH complementarity-determining region 2 results in a severe Ig secretion defect.
    Wiens GD; Lekkerkerker A; Veltman I; Rittenberg MB
    J Immunol; 2001 Aug; 167(4):2179-86. PubMed ID: 11490003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR; Den W; Sharon J
    J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic memory to phosphorylcholine (PC). VIII. Expression of the VH-12 gene product in the response to PC-keyhole limpet hemocyanin.
    Rittenberg MB; Glanville RW; Aebersold RH; Chang SP; Brown M
    Eur J Immunol; 1986 May; 16(5):503-7. PubMed ID: 3084285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion in HCDR3 rescues T15 antibody mutants from a secretion defect caused by mutations in HCDR2.
    Martin TM; Kowalczyk C; Stevens S; Wiens GD; Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1996 Nov; 157(10):4341-6. PubMed ID: 8906808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
    J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of mutations and selection in antibodies to the phosphocholine-specific determinant in Proteus morganii.
    Claflin JL; George J; Dell C; Berry J
    J Immunol; 1989 Nov; 143(9):3054-63. PubMed ID: 2478633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.
    Wiens GD; Brown M; Rittenberg MB
    J Immunol; 2003 May; 170(10):5095-102. PubMed ID: 12734355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
    J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic memory to PC-KLH: participation of the Q52 VH gene family.
    Stenzel-Poore MP; Hall TJ; Heusser CH; Faust CH; Rittenberg MB
    J Immunol; 1987 Sep; 139(5):1698-703. PubMed ID: 3114374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen.
    Chen C; Roberts VA; Rittenberg MB
    J Exp Med; 1992 Sep; 176(3):855-66. PubMed ID: 1512548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus.
    Kaveri SV; Kang CY; Köhler H
    J Immunol; 1990 Dec; 145(12):4207-13. PubMed ID: 2124238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacements in the exposed loop of the T15 antibody VH CDR2 affect carrier recognition of PC-containing pathogens.
    Brown M; Wiens GD; O'Hare T; Stenzel-Poore MP; Rittenberg MB
    Mol Immunol; 1999 Feb; 36(3):205-11. PubMed ID: 10403486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.
    Feeney AJ; Thuerauf DJ
    J Immunol; 1989 Dec; 143(12):4061-8. PubMed ID: 2512348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.